Previous studies using molecular and biochemical methods for refined assessment of HER2 levels and HER2 phosphorylation status have suggested that HER2 phosphorylation above a threshold occurs in a subgroup of HER2− breast tumors [31–35]. Here, ERBB2 is linked to breast neoplasm.